山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
38期
18-21
,共4页
苏永辉%徐家琪%卜巨源%李霄凌%侯冰宗
囌永輝%徐傢琪%蔔巨源%李霄凌%侯冰宗
소영휘%서가기%복거원%리소릉%후빙종
4-羟基-2,2,6,6-四甲基哌啶%肝硬化%肝脏缺血再灌注%肝功能
4-羥基-2,2,6,6-四甲基哌啶%肝硬化%肝髒缺血再灌註%肝功能
4-간기-2,2,6,6-사갑기고정%간경화%간장결혈재관주%간공능
4-Hydroxy-2.2.6.6-etram-ethyl-piperidinooxy%liver cirrhosis%reperfusion injury%liver function
目的:探讨4-羟基-2.2.6.6-四甲基哌啶( Tempo)对肝硬化大鼠肝组织缺血再灌注后肝功能的保护作用。方法取90只SD成年大鼠采用传统四氯化碳( CCL4)法制作肝硬化模型并随机分为假手术组、模型组及治疗组各30只。模型组及治疗组行开腹肝门阻断术(假手术组只暴露肝门,不阻断),肝门阻断后30 min恢复血流。治疗组术前缓慢静脉注射TEMPO 10 mg/100 g(用生理盐水稀释10倍),术后每12 h静注1次;模型组及假手术组术前均缓慢静脉注射与治疗组所用药物等体积的生理盐水,术后每12 h静注1次。术后72 h观察两组肝组织病理学变化、细胞凋亡情况;测定肝组织上清液超氧化物歧化酶( SOD)、过氧化物酶( CAT)、谷胱甘肽过氧化物酶( GSH-Px)活性及丙二醛( MDA)水平;测定三组肝功能指标。结果治疗组肝组织上清液中SOD、CAT、GSH-Px活性明显高于模型组(P<0.05),MDA水平明显低于模型组(P<0.05);ALT、AST及LDH水平明显低于模型组(P<0.05)。结论 TEMPO对肝硬化缺血再灌注损伤大鼠的肝功能有保护作用。
目的:探討4-羥基-2.2.6.6-四甲基哌啶( Tempo)對肝硬化大鼠肝組織缺血再灌註後肝功能的保護作用。方法取90隻SD成年大鼠採用傳統四氯化碳( CCL4)法製作肝硬化模型併隨機分為假手術組、模型組及治療組各30隻。模型組及治療組行開腹肝門阻斷術(假手術組隻暴露肝門,不阻斷),肝門阻斷後30 min恢複血流。治療組術前緩慢靜脈註射TEMPO 10 mg/100 g(用生理鹽水稀釋10倍),術後每12 h靜註1次;模型組及假手術組術前均緩慢靜脈註射與治療組所用藥物等體積的生理鹽水,術後每12 h靜註1次。術後72 h觀察兩組肝組織病理學變化、細胞凋亡情況;測定肝組織上清液超氧化物歧化酶( SOD)、過氧化物酶( CAT)、穀胱甘肽過氧化物酶( GSH-Px)活性及丙二醛( MDA)水平;測定三組肝功能指標。結果治療組肝組織上清液中SOD、CAT、GSH-Px活性明顯高于模型組(P<0.05),MDA水平明顯低于模型組(P<0.05);ALT、AST及LDH水平明顯低于模型組(P<0.05)。結論 TEMPO對肝硬化缺血再灌註損傷大鼠的肝功能有保護作用。
목적:탐토4-간기-2.2.6.6-사갑기고정( Tempo)대간경화대서간조직결혈재관주후간공능적보호작용。방법취90지SD성년대서채용전통사록화탄( CCL4)법제작간경화모형병수궤분위가수술조、모형조급치료조각30지。모형조급치료조행개복간문조단술(가수술조지폭로간문,불조단),간문조단후30 min회복혈류。치료조술전완만정맥주사TEMPO 10 mg/100 g(용생리염수희석10배),술후매12 h정주1차;모형조급가수술조술전균완만정맥주사여치료조소용약물등체적적생리염수,술후매12 h정주1차。술후72 h관찰량조간조직병이학변화、세포조망정황;측정간조직상청액초양화물기화매( SOD)、과양화물매( CAT)、곡광감태과양화물매( GSH-Px)활성급병이철( MDA)수평;측정삼조간공능지표。결과치료조간조직상청액중SOD、CAT、GSH-Px활성명현고우모형조(P<0.05),MDA수평명현저우모형조(P<0.05);ALT、AST급LDH수평명현저우모형조(P<0.05)。결론 TEMPO대간경화결혈재관주손상대서적간공능유보호작용。
Objective To investigate the protection of 4-Hydroxy-2.2.6.6-etram-ethyl-piperidinooxy(TEMPO) for liver function of cirrhotic rat after hepatic porta blocking.Methods The traditional carbon tetrachloride ( CCl4 ) method was used to induce liver cirrhosis in 90 adult rats and then equally divided into three groups, which were control group, model group and treatment group.Rats in model group and treatment group were adopted by open hepatic door and interdict operation to block liver door for 30 minutes and then restore blood flow ( rats in control group were adopted by exposed porta only without block) .Preoperative model group and control group were used normal saline ( as the volume of treatment group use) to intravenous injection slowly before operation and every 12 h after operation.Rats in treatment group were intrave-nous injected TEMPO at 10 mg/100 g (10 times diluted with saline water) before operation and static note once every 12 h after operation.All rats were taking the liver tissue and blood samples after operation 72 hours later.The liver tissue patho-logical changes and cell apoptosis were observed.The level of superoxide dismutase( SOD) , peroxidase ( CAT) ,glutathione peroxidase ( GSH-Px) activity and malondialdehyde ( MDA) of liver tissue clear liquid were tested.The liver function of three groups were tested.Results The SOD, CAT and GSH-Px activity of liver tissue in treatment group significantly higher than the model group(P<0.05).The MDA level in treatment group was significantly lower than model group(P<0.05), while liver function index was significantly lower than model group(P<0.05).Conclusions TEMPO can protect the rat liver function of cirrhotic rat after hepatic porta blocking.